Compare MX & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MX | INFU |
|---|---|---|
| Founded | 2003 | 2005 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 201.2M | 208.8M |
| IPO Year | 2007 | 2005 |
| Metric | MX | INFU |
|---|---|---|
| Price | $6.99 | $9.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $5.75 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 4.0M | 256.6K |
| Earning Date | 04-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 43.06 | ★ 181.82 |
| EPS | N/A | ★ 0.05 |
| Revenue | ★ $178,860,000.00 | $143,436,000.00 |
| Revenue This Year | $8.55 | $3.20 |
| Revenue Next Year | $6.37 | $7.31 |
| P/E Ratio | ★ N/A | $182.40 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $2.18 | $5.43 |
| 52 Week High | $9.86 | $11.04 |
| Indicator | MX | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 56.16 | 49.32 |
| Support Level | $2.66 | $8.57 |
| Resistance Level | N/A | $9.97 |
| Average True Range (ATR) | 1.15 | 0.51 |
| MACD | 0.18 | 0.01 |
| Stochastic Oscillator | 50.25 | 38.85 |
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The Company operates within a single operating segment, Power Solutions business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.